Hypertension, Vol 23, 468-475, Copyright © 1994 by American Heart Association
AS Hanson and SL Linas
Parathyroid hormone (PTH) has been implicated in hypertension, but PTH
infusion results in vasodilation. PTH activates adenylate cyclase in
vascular smooth muscle, but little is known about the factors that regulate
PTH receptor/adenylate cyclase coupling in vascular cells. To characterize
hormone-receptor signaling, we measured cyclic AMP levels in rat arterial
smooth muscle cells in culture exposed to PTH (bovine 1- 34). PTH yielded
time- and concentration-dependent increases in cyclic AMP levels. Compared
with isoproterenol, PTH was more potent, with a threshold at 2 x 10(-9)
versus 5 x 10(-8) mol/L and half maximal responses at 10(-8) versus 2.4 x
10(-7) mol/L. PTH-induced increases in cyclic AMP were independent of
extracellular calcium, cyclooxygenase metabolites, phospholipase C, and
protein kinase C because PTH-induced increases in cyclic AMP were not
prevented by variations in extracellular calcium, indomethacin, angiotensin
II, vasopressin, and protein kinase C activators or inhibitors.
PTH/adenylate cyclase coupling was G protein-dependent because increases in
cyclic AMP were prevented by preincubation with cholera toxin but not with
pertussis toxin. Prolonged exposure to PTH resulted in time- and
concentration- dependent homologous desensitization of cyclic AMP
responses. Desensitization occurred proximal to G protein/adenylate cyclase
because after prolonged PTH, responses to forskolin and cholera toxin
remained intact. Desensitization was independent of protein kinase A and
receptor sequestration because cyclic AMP responses remained after
prolonged exposure to forskolin and pretreatment with phenylarsine oxide,
colchicine, and cytochalasin D. We conclude that in vascular smooth muscle
cells, PTH is coupled to adenylate cyclase through a cholera
toxin-sensitive G protein.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells
Denver General Hospital Center, CO 80204-4507.
This article has been cited by other articles:
![]() |
D. Somjen, Y. Weisman, F. Kohen, B. Gayer, R. Limor, O. Sharon, N. Jaccard, E. Knoll, and N. Stern 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds Circulation, April 5, 2005; 111(13): 1666 - 1671. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Andersson, E. Rydberg, and R. Willenheimer Primary hyperparathyroidism and heart disease -- a review Eur. Heart J., October 2, 2004; 25(20): 1776 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fallo, G. Camporese, E. Capitelli, G. M. Andreozzi, F. Mantero, and F. Lumachi Ultrasound Evaluation of Carotid Artery in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2096 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Marchais, F. Metivier, A. P. Guerin, and G. M. London Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2178 - 2183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Picotto, V. Massheimer, and R. Boland Parathyroid hormone stimulates calcium influx and the cAMP messenger system in rat enterocytes Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1349 - C1353. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |